Exacerbation prediction and aerosol emissions
Investigating the impact of aerosol emissions on patients with COPD and asthma.
Theme Respiratory disease
This workstream has two parts. The first focuses on aerosol emissions. Aerosol emissions are particles people breathe out when talking, breathing, sneezing or coughing. Our work will look at the aerosols that people with lung disease create in various environments. This will help us understand the risk of airborne infections such as COVID-19 better.
Second, we will gather mobile app data from patients with chronic obstructive pulmonary disease (COPD) and asthma. We will use this data to see if we can predict when these patients may have a lung attack or ‘exacerbation’. Our aim is to help them avoid being admitted into hospital.
This work is especially important within population groups that are disproportionately affected by these diseases. To achieve this, we’re working with engineers, technology partners and other respiratory BRC themes in the UK, with access to different populations.
AERATOR collaboration
Theme Respiratory disease
Workstream Exacerbation prediction and aerosol emissions
Sensing, Prediction and Alerts in COPD Exacerbations (SPACE) Study I
Theme Respiratory disease
Workstream Exacerbation prediction and aerosol emissions
Saliva biomarkers in chronic obstructive pulmonary disease exacerbation
Theme Respiratory disease
Workstream Exacerbation prediction and aerosol emissions
Sensing, Prediction and Alerts in COPD Exacerbations (SPACE) Study II
Theme Respiratory disease
Workstream Exacerbation prediction and aerosol emissions
BREATHE study
Theme Respiratory disease
Workstream Exacerbation prediction and aerosol emissions